TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT01737580 — Predictive Biomarker (PRD): TLR7 mRNA
Genes: TLR7; UNQ248/PRO285
Study NCT02053818 — Predictive Biomarker (PRD): TNNT1 mRNA
Genes: TNNT1; TNT
Study NCT03117816 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT03117816 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00867165 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00867165 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT00867165 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study NCT01805752 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02483780 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03703167 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT00617344 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04637269 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT01370590 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01029223 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01373528 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT01373528 — Surrogate Endpoint (SUR): Urine free cortisol
Study NCT04440566 — Predictive Biomarker (PRD): OGT mRNA
Genes: OGT
Study NCT03302260 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02118727 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02693002 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT02906163 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02048228 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT00072267 — Predictive Biomarker (PRD): UCN mRNA
Genes: UCN
Study NCT03632941 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01274091 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study NCT00941330 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00455065 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03429803 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT03637218 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT04506645 — Predictive Biomarker (PRD): NPR1 mRNA
Genes: NPR1; ANPRA
Study NCT04506645 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04506645 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01891175 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04717453 — Safety Biomarker (SAF): Ornithine transcarbamylase
Genes: OTC
Study NCT01832558 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT01832558 — Surrogate Endpoint (SUR): Serum potassium
Study NCT02819752 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT03950752 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT00350597 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00254826 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT02627703 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT03073252 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00430703 — Predictive Biomarker (PRD): EP300 mRNA
Genes: EP300; P300
Study NCT03236584 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05215964 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05215964 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT03203330 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT00565773 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT04001634 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03391934 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03391934 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02032082 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02032082 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study NCT03165747 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02781675 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02781675 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02999074 — Surrogate Endpoint (SUR): Pathological complete response
Study NCT02669459 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04505410 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00485277 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01488526 — Monitoring Biomarker (MOI): HBV DNA
Study NCT03930693 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01522716 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01512758 — Predictive Biomarker (PRD): Aurora kinase A
Genes: AURKA; AIK; AIRK1; ARK1; AURA; AYK1; BTAK; IAK1; STK15; STK6
Study NCT03270540 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03015168 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT03154385 — Predictive Biomarker (PRD): TNFSF13B mRNA
Genes: TNFSF13B; BAFF; BLYS; TALL1; TNFSF20; ZTNF4; UNQ401/PRO738
Study NCT02932540 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02184975 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT04074668 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02277184 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT02277184 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT03500991 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT03612778 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04470635 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02426840 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00010010 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04218032 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02234791 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT01683539 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT01683539 — Safety Biomarker (SAF): BDNF
Study NCT04463420 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04243707 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04579471 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT02876445 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT02551653 — Predictive Biomarker (PRD): PTK2 mRNA
Genes: PTK2; FAK; FAK1
Study NCT04324723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00111267 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT04076592 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04076592 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05021016 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT03955913 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT02497443 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT02341742 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02334475 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02334475 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01962532 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study NCT04863391 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01645215 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT01955642 — Predictive Biomarker (PRD): PGP mRNA
Genes: PGP
Study NCT03169335 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT04469972 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00602043 — Predictive Biomarker (PRD): FES mRNA
Genes: FES; FPS
Study NCT00602043 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02209688 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02209688 — Safety Biomarker (SAF): Cytochrome P450 2D6
Genes: CYP2D6; CYP2DL1
Study NCT02815007 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00972309 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-A
Study NCT01416974 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01661764 — Predictive Biomarker (PRD): FADS1 mRNA
Genes: FADS1; FADSD5
Study NCT01661764 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02758275 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02570919 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study NCT03697551 — Predictive Biomarker (PRD): SSTR2 mRNA
Genes: SSTR2
Study NCT02605551 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00216112 — Predictive Biomarker (PRD): KITLG mRNA
Genes: KITLG; MGF; SCF
Study NCT00216112 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT03581903 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT01565278 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT01223352 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT03162198 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT05595252 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT02401165 — Predictive Biomarker (PRD): PPP1R15A mRNA
Genes: PPP1R15A; GADD34
Study NCT00819143 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT00819143 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00819143 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT02773004 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT01016665 — Predictive Biomarker (PRD): Ki-67
Genes: MKI67; MIB-1; PPP1R105
Study NCT04042701 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04042701 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03732352 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03392246 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04098562 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT03112382 — Predictive Biomarker (PRD): SLC30A8 mRNA
Genes: SLC30A8; ZNT8
Study NCT04188275 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT00501280 — Predictive Biomarker (PRD): PON1 mRNA
Genes: PON1; PON
Study NCT00072137 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01759797 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT03193775 — Monitoring Biomarker (MOI): HBV DNA
Study NCT01139710 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06371105 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02592980 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT02366624 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study NCT02366624 — Predictive Biomarker (PRD): PYY mRNA
Genes: PYY
Study NCT00332930 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01751984 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01496963 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT00329368 — Predictive Biomarker (PRD): GPI mRNA
Genes: GPI
Study NCT00329368 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT02495129 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03093922 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT01556373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01556373 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00546585 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00860535 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT00776984 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04154956 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study NCT04500769 — Safety Biomarker (SAF): miR-1
Study NCT00223860 — Predictive Biomarker (PRD): GNRH1 mRNA
Genes: GNRH1; GNRH; GRH; LHRH
Study NCT00223860 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT03349619 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT03349619 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT03878706 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT03878706 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01038375 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01171248 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04644250 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT01350180 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT01350180 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT02849145 — Predictive Biomarker (PRD): GNAQ mRNA
Genes: GNAQ; GAQ
Study NCT02849145 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT03213223 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01994174 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01994174 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02965950 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study NCT02965950 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03946748 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study NCT01692951 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT01265927 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04631159 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04542213 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT01674829 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study NCT03499184 — Surrogate Endpoint (SUR): Bacterial count
Study NCT03499184 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT01855971 — Predictive Biomarker (PRD): MAPK3 mRNA
Genes: MAPK3; ERK1; PRKM3
Study NCT01855971 — Pharmacodynamic Biomarker (PDY): Extracellular signal-regulated kinase
Study NCT03568773 — Predictive Biomarker (PRD): FTO mRNA
Genes: FTO; KIAA1752
Study NCT04392375 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00740948 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT00740948 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00353717 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00353717 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT00353717 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04322552 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT02731690 — Predictive Biomarker (PRD): GNE mRNA
Genes: GNE; GLCNE
Study NCT01856647 — Predictive Biomarker (PRD): SAT1 mRNA
Genes: SAT1; SAT
Study NCT00555880 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02077257 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT01074918 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02685098 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT03584165 — Predictive Biomarker (PRD): CHM mRNA
Genes: CHM; REP1; TCD
Study NCT00513188 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 2 receptor alpha
Genes: IL2RA
Study NCT01037556 — Predictive Biomarker (PRD): AKR1C3 mRNA
Genes: AKR1C3; DDH1; HSD17B5; KIAA0119; PGFS
Study NCT02565849 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00799266 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02444390 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT01109602 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00943852 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02702388 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT04679311 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03169790 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT01656200 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04183374 — Surrogate Endpoint (SUR): Sperm parameters
Study NCT04546009 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04546009 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT04546009 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03864198 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT00776295 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT03582527 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study NCT00418886 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00418886 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00418886 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01134614 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00613496 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03512171 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study NCT03512171 — Safety Biomarker (SAF): DRD2
Study NCT02589990 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02589990 — Predictive Biomarker (PRD): ACTN3 mRNA
Genes: ACTN3
Study NCT02589990 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study NCT03374449 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT00130325 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01874288 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT01874288 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study NCT03225326 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04330664 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT03490838 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT03929107 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT00247403 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT03258710 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02449382 — Surrogate Endpoint (SUR): Serum sodium
Study NCT00323791 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT00668265 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study NCT03923790 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01793623 — Predictive Biomarker (PRD): KLHL17 mRNA
Genes: KLHL17; AF
Study NCT02449005 — Surrogate Endpoint (SUR): Probing pocket depth
Study NCT00632489 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05010343 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT01620229 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT04835779 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT01955408 — Predictive Biomarker (PRD): SUFU mRNA
Genes: SUFU; UNQ650/PRO1280
Study NCT03074630 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT02763644 — Pharmacodynamic Biomarker (PDY): Complement C5
Genes: C5; CPAMD4
Study NCT02382445 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03387553 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02905448 — Surrogate Endpoint (SUR): Serum LDL cholesterol
Study NCT02905448 — Surrogate Endpoint (SUR): Serum triglycerides
Study NCT02905448 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT00818779 — Pharmacodynamic Biomarker (PDY): Angiotensinogenase renin
Genes: REN
Study NCT00818779 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02302378 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03793036 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01135615 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor 23
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study NCT04842370 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study NCT04557553 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03494153 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03796377 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT02521142 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02521142 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT06613633 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06613633 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00003663 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20